Depression News and Research

Latest Depression News and Research

Study finds depression as a risk factor for Alzheimer's disease

Depression is commonly reported in people with Alzheimer's disease and its precursor, mild cognitive impairment, with several studies suggesting having a history of major depression may nearly double your risk of developing dementia later in life. However, it has been unclear if depression is a symptom of the disease or a potential cause of the disease.

6 Jul 2010

Depression increases risk of developing dementia later in life

A new study shows that having depression may nearly double your risk of developing dementia later in life. The research will be published in the July 6, 2010, issue of Neurology-, the medical journal of the American Academy of Neurology.

6 Jul 2010

Anxiety disorders associated with higher risk of cardiovascular events, deaths in heart disease patients

Among patients with heart disease, anxiety disorders appear to be associated with a higher risk of stroke, heart attack, heart failure and death, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

6 Jul 2010

Depression and dementia may go hand in hand: Study

A new study has found that depressive disorders raise the risk of dementia. The findings of this study were published in the journal Neurology. The study involved nearly 1,000 people who were studied for up to 17 years. Those who were depressed when first examined almost doubled their risk for dementia and also increased their risk for Alzheimer's disease the study authors wrote.

5 Jul 2010

The heart and the psyche – Link between heart disease and anxiety-depressive disorders

According to a new report published in the acclaimed journal Archives of General Psychiatry, concomitant anxiety and other psychiatric illnesses in heart patients raise their risk of getting heart attacks, strokes, heart failure and early death.

5 Jul 2010

Women have longer life expectancy, but with prevalence of disability in old age

Although women have a longer life expectancy, they experience a much greater prevalence of disability in old age than men do. This is the main conclusion of the study published in the latest issue of the Journal of Women's Health.

3 Jul 2010

Dogs help soldiers recover from PTSD

The Army is using dogs "much more" to help soldiers recovering from post-traumatic stress disorder (PTSD) according to the Army Surgeon General's special assistant for mental health, Col. Elspeth Cameron Ritchie, M.D., who spoke today at the annual convention of the National Alliance on Mental Illness (NAMI).

3 Jul 2010

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

Chelsea Therapeutics International, Ltd. announced the completion and favorable outcome of an independent Data Monitoring Committee (DMC) review of the safety and efficacy data from approximately half the target enrollment in Chelsea's Phase II trial of droxidopa in fibromyalgia.

2 Jul 2010

FDA approves Purdue's Butrans Transdermal System CIII for management of chronic pain

Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.

2 Jul 2010

Imbalance in neuroendocrine system linked to depression in MS patients: Study

Now, in the first such study in living humans, researchers at UCLA suggest a cause, and it's not psychological, but physical: atrophy of a specific region of the hippocampus, a critical part of the brain involved in mood and memory, among other functions.

2 Jul 2010

Does too much texting puts teenagers at risk?

A seemingly harmless method of communication - text messaging on mobile phones could damage teenagers physically and psychologically a new study has revealed.

1 Jul 2010

Hospira subsidiary completes tender offer for Javelin's outstanding shares of common stock

Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc..

1 Jul 2010

AstraZeneca announces new support program for patients on ARIMIDEX

AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.

1 Jul 2010

Aptuit to acquire GSK's research business in Verona

GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.

1 Jul 2010

Euthymics and DOV sign merger agreement

Euthymics Bioscience, Inc., a privately held Delaware corporation, and DOV Pharmaceutical, Inc., a Delaware corporation currently traded on the Pink Sheets, today jointly announced that they have signed a merger agreement in connection with the pending merger and acquisition of DOV by Euthymics.

1 Jul 2010

First analyses on impact of Medicare Part D presented at UMB's 2010 Academy/Health Annual Meeting

Some of the first analyses on the impact of Medicare Part D, as well as new insights on drug adherence patterns by chronic disease patients, will be presented today and tomorrow at the 2010 Academy/Health Annual Meeting by several University of Maryland, Baltimore teams of pharmaceutical health services researchers.

1 Jul 2010

Evotec commences EVT 101 proof-of-concept Phase II study in treatment-resistant depression

Evotec AG today announced the start of the proof-of-concept Phase II study in treatment-resistant depression with its NR2B subtype selective NMDA receptor antagonist EVT 101. This clinical development is part of an alliance between Evotec and Roche.

1 Jul 2010

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Scientists are reporting a possible explanation for the symptoms of anxiety and depression that occur in some patients taking the popular statin family of anti-cholesterol drugs, and reported by some individuals on low-cholesterol diets. These symptoms could result from long-term, low levels of cholesterol in the brain, the report suggests. It appears in ACS' weekly journal Biochemistry.

1 Jul 2010

Neuralstem announces completion of $10 million registered direct offering

Neuralstem, Inc. (NYSE Amex: CUR) announced that it has completed its previously announced registered direct offering of $10 million of units to institutional investors. The units were priced at $2.80 and consisted of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an exercise price of $3.25 and a term of three years. Net proceeds from this offering, after deducting placement agent fees and other offering expenses, total approximately $9.2 million. All of the securities were offered pursuant to an effective shelf registration statement.

1 Jul 2010

Focus shifts to mental health policies

According to Health Minister Nicola Roxon, the Coalition has gone “crazy” for providing funds to promote its mental health policy by closing down the Labour health reforms in general practice and record keeping.

1 Jul 2010

Depression News and Research

Latest Depression News and Research

Study finds depression as a risk factor for Alzheimer's disease

Depression increases risk of developing dementia later in life

Anxiety disorders associated with higher risk of cardiovascular events, deaths in heart disease patients

Depression and dementia may go hand in hand: Study

The heart and the psyche – Link between heart disease and anxiety-depressive disorders

Women have longer life expectancy, but with prevalence of disability in old age

Dogs help soldiers recover from PTSD

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

FDA approves Purdue's Butrans Transdermal System CIII for management of chronic pain

Imbalance in neuroendocrine system linked to depression in MS patients: Study

Does too much texting puts teenagers at risk?

Hospira subsidiary completes tender offer for Javelin's outstanding shares of common stock

AstraZeneca announces new support program for patients on ARIMIDEX

Aptuit to acquire GSK's research business in Verona

Euthymics and DOV sign merger agreement

First analyses on impact of Medicare Part D presented at UMB's 2010 Academy/Health Annual Meeting

Evotec commences EVT 101 proof-of-concept Phase II study in treatment-resistant depression

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Neuralstem announces completion of $10 million registered direct offering

Focus shifts to mental health policies

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in